Clinical Trials on Skin Lightening in Belgium

Total 1662 results

University Medicine Greifswald
Universitaire Ziekenhuizen KU Leuven; Nij Smellinghe Hosptial; KABEG Management

Unknown

Therapeutical Assessment of Compression Armsleeves for Lymphatic Indications (BF09-PH-01)

Lymphedema

Belgium, Austria, Germany, Netherlands
Universitaire Ziekenhuizen KU Leuven

Completed

Synaptic Density and Progression of Huntington's Disease.

Huntington Disease

Belgium
Ziarco Pharma Ltd

Completed

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

Atopic Dermatitis

Belgium, Germany, Poland, United Kingdom
Centre Francois Baclesse
Sanofi; National Cancer Institute, France

Completed

Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon (COG AGE)

Breast Cancer

France, Belgium
Galderma R&D

Completed

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Psoriasis Vulgaris

United States, Canada, Belgium, Germany, Italy
Cadila Pharnmaceuticals
Lipidor AB, Svärdvägen 13 SE-182 33 Danderyd, Sweden

Completed

A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis (AKP01)

Mild to Moderate Plaque Psoriasis

India
AZ-VUB
Universitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis Brussel

Completed

Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

Breast Cancer

Belgium
Sanofi

Terminated

Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer

Spain, Belgium, Italy, Czechia, Netherlands
KU Leuven

Unknown

Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs

Neurofibromatosis Type 1

Belgium
University Ghent
3M

Completed

Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence

Diaper Rash | Incontinence-associated Dermatitis | Irritant Contact Dermatitis

Belgium
AstraZeneca

Completed

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Advanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast Cancer

Belgium, Netherlands, United Kingdom
UCB Pharma

Completed

Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

Immune System Diseases | Autoimmune Diseases | Lupus Erythematosus, Systemic | Skin and Connective Tissue Diseases | Connective Tissue Disease

Belgium, Bulgaria, Germany
Pfizer

Terminated

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Breast Cancer

United States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
Cytori Therapeutics

Completed

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy (RESTORE-2)

Breast Neoplasms | Carcinoma, Ductal, Breast | Mammaplasty | Mastectomy, Segmental, Lumpectomy, Breast Reconstruction,

Spain, United Kingdom, Belgium, Italy
Swiss Group for Clinical Cancer Research

Completed

Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

Breast Cancer

Switzerland, Belgium
ERYtech Pharma

Terminated

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

Triple Negative Breast Cancer

Spain, Belgium, Hungary
Leiden University Medical Center

Terminated

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) (HR-GCT)

Giant Cell Tumor of Bone | Osteoclastoma

Netherlands, Belgium
Labo'Life

Recruiting

Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts (EVAsION)

Plantar Wart | Common Wart | Flat Wart

Belgium
Tel-Aviv Sourasky Medical Center
KU Leuven; Michael J. Fox Foundation for Parkinson's Research

Completed

Digital Wearable Walking Aid for Freezing of Gait in Parkinson´s Disease

Parkinson Disease

Israel, Belgium
Evgen Pharma
Premier Research Group plc

Completed

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (STEM)

Breast Neoplasm

United Kingdom, Belgium, France, Spain
Jules Bordet Institute
Hoffmann-La Roche

Active, not recruiting

Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (ROSALINE)

HER2-negative Breast Cancer | ER+ Breast Cancer | Invasive Lobular Breast Carcinoma

France, Belgium
KU Leuven

Unknown

Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients

Neurofibromatosis Type 1

Belgium
DNAlytics
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Unknown

Predictive Analytics for Theranosis in RA (PAnTheRA)

Rheumatoid Arthritis

Belgium, Spain
Autonomic Technologies, Inc.

Completed

Pathway CH-1 Long-Term Follow-Up

Chronic Cluster Headache

Spain, Belgium, Denmark
UNICANCER

Active, not recruiting

My Personalized Breast Screening (MyPeBS)

Breast Screening

France, Belgium, Israel, Italy, Spain, United Kingdom
Novartis Pharmaceuticals

Completed

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER-2 Positive Breast Cancer

Belgium, Netherlands, Australia, Italy, United States
European Organisation for Research and Treatment...
GlaxoSmithKline

Completed

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Breast Cancer

France, United Kingdom, Belgium, Switzerland, Slovenia
Maastricht University Medical Center
Erasmus Medical Center; Jules Bordet Institute; Academisch Ziekenhuis Maastricht

Recruiting

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Unspecified Adult Solid Tumor, Protocol Specific

Netherlands, Belgium
AbbVie

Recruiting

An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO) (IMMagine)

Psoriasis

Canada, Belgium, Germany
Boehringer Ingelheim

Completed

A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Scleroderma, Systemic

Spain, Germany, France, Belgium, Portugal, Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer
Amgen

Completed

Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

Psoriasis

Belgium, France, Spain, Germany, Italy, Austria, Poland, Romania, Netherlands, Hungary
Pfizer

Terminated

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Breast Cancer Metastatic

United States, Spain, Belgium, Italy
Universitaire Ziekenhuizen KU Leuven
Norwegian Institute of Public Health; KU Leuven; University Ghent; Sciensano

Completed

Evidence-based Laboratory Test Order Sets in Primary Care

Liver Diseases | Cardiovascular Diseases | Sexually Transmitted Diseases | Hypertension | Obesity | Diabetes Mellitus | Fatigue | Chronic Kidney Diseases | Thyroid Diseases | Rheumatoid Arthritis | Diarrhea | Anemia | Acute Coronary Syndrome | Gout | Lung Embolism | Medication Monitoring | General Check-up

Belgium
Hoffmann-La Roche

Completed

A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium
Fidia Farmaceutici s.p.a.

Completed

Evaluation of the Evolution of Biological and Imaging Markers of Bone and Cartilage Degradation in Patients With Knee Osteoarthritis Receiving Intra-articular Injections of a Hyaluronan Derivative HYMOVIS® (MOKHA)

Knee Osteoarthritis

Belgium, France
Universitair Ziekenhuis Brussel

Unknown

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

Sleep Disorder

Belgium
Autonomic Technologies, Inc.

Completed

Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache (Pathway M-1)

High Frequency, High Disability Migraine

Belgium, Denmark, Spain
AbbVie (prior sponsor, Abbott)

Completed

Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.

Rheumatoid Arthritis

Belgium, Czech Republic
Vlaamse Vereniging voor Obstetrie en Gynaecologie

Completed

An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients (CYPTAMBRUT-2)

ER-positive Breast Cancer

Belgium
European Organisation for Research and Treatment...
Central and Eastern European Oncology Group; Grupo Oncologico Cooperativo Chileno... and other collaborators

Terminated

Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy

Breast Cancer

Poland, Belgium, Netherlands, Israel, United Kingdom, Chile, Portugal
Smith & Nephew Orthopaedics AG
Iqvia Pty Ltd; eResearchTechnology, Inc; M Squared Associates,Inc.; ExecuPharm...

Completed

Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe (R3 EU PAS)

Degenerative Joint Disease of Hip

Belgium, Finland, Spain, United Kingdom
KU Leuven
University of Kiel

Completed

The Effect of Split-belt Treadmill Training on Gait in Parkinson's Disease

Parkinson Disease | Freezing of Gait

Belgium, Germany
Vrije Universiteit Brussel
Jessa Hospital; Universitair Ziekenhuis Brussel; Erasmus University Rotterdam; Odisee... and other collaborators

Completed

Exploratory Study About the Implementation of Technology in the Rehabilitation

Stroke | Covid19 | Parkinson Disease | Neglect, Hemispatial

Belgium
University Hospital, Ghent
Centre Hospitalier Universitaire Vaudois; University Ghent; Hopital Lariboisière and other collaborators

Completed

PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer (PIPAC-nabpac)

Breast Cancer Stage IV | Peritoneal Carcinomatosis | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV | Breast Cancer Stage IIIB | Breast Cancer Stage IIIc | Ovarian Cancer Stage IIIB | Stomach Cancer Stage III | Stomach Cancer Stage IV With Metastases | Pancreas Cancer, Stage III | Pancreas Cancer, Stage...

Belgium
Eisai Inc.

Approved for marketing

An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory

Metastatic Breast Cancer

Canada, Belgium, France
ETOP IBCSG Partners Foundation
Breast International Group

Completed

Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)

Metastatic Breast Cancer

United Kingdom, Belgium, Italy
argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
Jules Bordet Institute
AstraZeneca

Active, not recruiting

Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (SYNERGY)

Triple Negative Breast Cancer

France, Belgium
Novartis Pharmaceuticals

Completed

A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

Metastatic or Locally Advanced Solid Tumors

Netherlands, Spain, Germany, Switzerland, Belgium
Medacta International SA

Active, not recruiting

The Medacta International GMK Sphere Post-Marketing Surveillance Study

Arthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis | Poly-arthritis

Belgium, United Kingdom

Clinical Trials on Skin Lightening in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations